MERCURYLABORATORIESLTD logo

Mercury Laboratories Ltd

MERCURYLABORATORIESLTD·NSE·
₹0.00▲ +0.00 (+0.00%)
Market Cap91.35 Cr
PE Ratio23.00
Volume—
Day High - Low—
52W High-Low942.90 - 620.55

Mercury Laboratories Ltd (MERCURYLABORATORIESLTD): company summary

Mercury Laboratories Ltd (MERCURYLABORATORIESLTD) is a micro-cap Healthcare company valued at ₹91 crore operating in Pharmaceuticals on the NSE and BSE.

Mercury Laboratories Ltd (MERCURYLABORATORIESLTD) is a micro-cap Healthcare company valued at ₹91 crore operating in Pharmaceuticals on the NSE and BSE.

Financial performance
Revenue has been growing slowly at 0.3% a year over three years; profit fell 3.7% a year, behind revenue — margins are under pressure. Return on equity is 9.2%.
Valuation multiples
The stock trades at 23.0 times earnings, a discount to the Healthcare median of 32.0, 1.65 times book value. It yields 0.4%.

Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
DocStoX Score
3.9/10
Poor
Fair Value
Sign in to see
ROE
9.19%
Average
P/E
23.00x
Fair
Debt / Equity
0.15
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Poor

Price performance

52W₹620.55
₹942.90
DocStoX take

Supported by risk (6.5), but held back by growth (1.3). Scored on 4 of 5 measures.

DocStoX score

Medium confidence
3.9
/10
Poor
Quality
Modest
ROE 9.2%
Valuation
Rich
P/E 23.0×
Growth
Flat
Revenue +2.0% 5Y CAGR
Risk
Moderate
D/E 0.15
Momentum
No data
No technical indicators

Scored on 4 of 5 measures — the rest have no data for this company.

At a glance

Market Cap
₹91 Cr
52W High / Low
₹943 / ₹621
Dividend Yield
0.44%
Promoter Holding
73.66%
EPS (TTM)
₹26.17
Book Value
₹484.00

Key highlights

  • Low leverage — D/E 0.15
  • Profitable in all of the last 5 years
  • Profit shrinking 1% a year
  • Growth is weak (1.3/10)
2 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Mercury Laboratories Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.